<p>NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therape
<p>ECB sources:</p><ul><li>Agreed to debate PEPP reinvestment end date this winter, and minimum reserves as part of the framework review.</li><li>ECB policymakers d
Leave a Comment